Loading...
Chemical structure of BMS-986189

GC26736

BMS-986189

Also known as 2-[3-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-42-(2-aminoethyl)-6-(aminomethyl)-15-(2-amino-2-oxoethyl)-27-[(2-amino-2-oxoethyl)carbamoyl]-33,36-dibutyl-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-39-yl]methyl]indol-1-yl]acetic acid

BMS-986189 is a macrocyclic peptide inhibitor of PD-L1 (IC50: 1·03 nM), and can be used for cancer research

ChemicalCAS1629665-96-8MW1887.21FormulaC91H131N21O21S
CAS number
1629665-96-8
Molecular weight
1887.21
Formula
C91H131N21O21S
Solubility
DMSO ： ≥ 100 mg/mL (52·99 mM)
InChIKey
RHPNSCBSKKTHPG-UHADKVPGSA-N
Catalogue number
GC26736
Brand
GLPBIO
Computed properties PubChem CID 124085715 · XLogP -0.5 · TPSA 655 Ų · H-bond donors 18
XLogP
-0.5
TPSA
655 Ų
H-bond donors
18
H-bond acceptors
24
Rotatable bonds
26
Heavy atoms
134

SMILES CCCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSCC(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N1C)CCCC)C)CC4=CN(C5=CC=CC=C54)CC(=O)O)CCN)CC6=CNC7=CC=CC=C76)O)CC(C)C)CN)CC(=O)N)C)C)CC8=CC=C(C=C8)O)C(=O)NCC(=O)N)CC(C)C

Computed descriptors from PubChem (CID 124085715), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.